| |
| |
|
| Insider
Information: |
Ajer Jeffrey Robert |
| Relationship: |
Director |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
100,920 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,960,592 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
100,920 |
|
|
| Total
Value |
$5,960,592 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -61.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Commercial ... |
2024-05-02 |
66,767 |
|
0 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
Director |
2023-09-18 |
34,153 |
2017-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
174 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-06-02 |
4 |
AS |
$57.83 |
$21,804 |
D/D |
(377) |
20,190 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-05-31 |
4 |
D |
$57.96 |
$23,937 |
D/D |
(413) |
20,567 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-05-07 |
4 |
AS |
$85.96 |
$26,562 |
D/D |
(309) |
52,914 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-05-13 |
4 |
AS |
$58.18 |
$27,809 |
D/D |
(478) |
23,080 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2013-06-03 |
4 |
AS |
$58.34 |
$28,763 |
D/D |
(493) |
14,880 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2017-05-02 |
4 |
AS |
$96.74 |
$29,215 |
D/D |
(302) |
51,532 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-05-12 |
4 |
D |
$59.30 |
$30,955 |
D/D |
(522) |
23,558 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2013-05-08 |
4 |
D |
$65.32 |
$31,941 |
D/D |
(489) |
10,081 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2016-05-03 |
4 |
AS |
$86.03 |
$35,701 |
D/D |
(415) |
63,072 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-05-09 |
4 |
AS |
$57.96 |
$35,992 |
D/D |
(621) |
24,080 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-05-08 |
4 |
D |
$56.78 |
$38,554 |
D/D |
(679) |
24,701 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-05-01 |
4 |
AS |
$59.55 |
$39,661 |
D/D |
(666) |
25,380 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2019-09-30 |
4 |
AS |
$18.06 |
$42,893 |
D/D |
(2,375) |
22,375 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2020-09-21 |
4 |
AS |
$19.74 |
$44,415 |
D/D |
(2,250) |
20,125 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2019-09-20 |
4 |
AS |
$20.24 |
$45,540 |
D/D |
(2,250) |
18,250 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2015-06-01 |
4 |
AS |
$123.76 |
$46,657 |
D/D |
(377) |
38,455 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2015-04-30 |
4 |
A |
$51.26 |
$48,341 |
D/D |
943 |
43,033 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2013-05-12 |
4 |
D |
$67.68 |
$50,895 |
D/D |
(752) |
8,518 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2013-05-01 |
4 |
AS |
$64.52 |
$51,420 |
D/D |
(797) |
10,570 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2015-05-31 |
4 |
D |
$125.57 |
$51,860 |
D/D |
(413) |
38,832 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2013-05-09 |
4 |
AS |
$66.00 |
$53,528 |
D/D |
(811) |
9,270 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2016-05-06 |
4 |
D |
$80.80 |
$54,863 |
D/D |
(679) |
62,393 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2020-09-28 |
4 |
AS |
$17.25 |
$56,063 |
D/D |
(3,250) |
25,975 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-05-16 |
4 |
AS |
$56.91 |
$57,136 |
D/D |
(1,004) |
20,980 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-05-15 |
4 |
D |
$57.44 |
$62,954 |
D/D |
(1,096) |
21,984 |
0 |
- |
|
174 Records found
|
|
Page 3 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
